日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling

COLEC12高表达的肿瘤相关巨噬细胞通过旁分泌NRG1-HER2/HER3信号通路调控肝细胞癌的乐伐替尼耐药性和癌症干细胞特性

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2025.1059
Zhang, Jianxing; Qiao, Liang; Wu, Zongfeng; Zuo, Dinglan; Huang, Shanshan; Liu, Shaoru; Huang, Zhenkun; Zeng, Yi; Li, Yu; Yuan, Yichuan; Wang, Chenwei; He, Wei; Qiu, Jiliang; Yuan, Yunfei; Niu, Yi; Li, Binkui
信号转导
免疫/内分泌
细胞生物学
巨噬细胞
HER2
发育与干细胞
巨噬细胞
干细胞
肿瘤
肿瘤免疫
COL
发表日期：2026
文献求助 收藏

USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma

USP14介导的代谢竞争会损害肝细胞癌中CD8+ T细胞的免疫监视功能。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2510576122
Yuan, Yichuan; Niu, Yi; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zuo, Dinglan; Zhong, Chengrui; Li, Kai; Guan, Xin-Yuan; Yuan, Yunfei; Li, Binkui
肿瘤
T细胞
肿瘤免疫
CD8
代谢
USP14
T细胞
SP1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

调控因子 X1 通过转录调控 BECN1 促进索拉非尼诱导的肝细胞癌铁死亡

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-01017-6
Yang Zhiwen, Yuan Yichuan, Niu Yi, Zuo Dinglan, Liu Wenwu, Li Kai, Shi Yunxing, Qiu Zhiyu, Li Keren, Lin Zhu, Zhong Chengrui, Huang Zhenkun, He Wei, Guan Xinyuan, Yuan Yunfei, Zeng Weian, Qiu Jiliang, Li Binkui
细胞生物学
转录调控
铁死亡
发表日期：2025
文献求助 收藏

Application effectiveness analysis of diversified teaching combined with virtual simulation experiments in standardized training for orthopedic residents

骨科住院医师标准化培训中多元化教学结合虚拟仿真实验的应用效果分析

期刊:BMC Medical Education
影响因子:3.2
doi:10.1186/s12909-025-07759-7
Liu, Xiao; Yuan, Yunfei; Zhou, Feifei
发表日期：2025
文献求助 收藏

Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial

乙型肝炎病毒相关肝细胞癌合并临床显著性门静脉高压患者的肝部分切除术与介入治疗：一项随机对照临床试验

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12614
Yuan, Yichuan; Peng, Hong; He, Wei; Zheng, Yun; Qiu, Jiliang; Chen, Bin; Zou, Ruhai; Wang, Chenwei; Lau, Wan Yee; Li, Binkui; Yuan, Yunfei
肿瘤
肿瘤免疫
微生物学
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

m(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma

m(6)A介导的lnc-OXAR通过增强Ku70稳定性促进非酒精性脂肪性肝炎相关肝细胞癌的奥沙利铂耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-024-03134-4
Lin, Zhu; Huang, Zhenkun; Qiu, Jiliang; Shi, Yunxing; Zuo, Dinglan; Qiu, Zhiyu; He, Wei; Niu, Yi; Yuan, Yunfei; Li, Binkui
肿瘤
肿瘤免疫
Ku70
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study

对于最初无法切除的肝细胞癌患者，在转化治疗后获得放射学完全缓解，观察等待策略与手术切除策略的比较：一项倾向评分匹配的比较研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001155
Li, Binkui; Wang, Chenwei; He, Wei; Qiu, Jiliang; Zheng, Yun; Zou, Ruhai; Lin, Zhu; Shi, Yunxing; Yuan, Yichuan; Zhang, Rong; Zhang, Chao; Chen, Minshan; Lau, Wan Yee; Yuan, Yunfei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Overexpression of PDSS2-Del2 in HCC promotes tumor metastasis by interacting with macrophages

PDSS2-Del2在肝细胞癌中的过度表达通过与巨噬细胞相互作用促进肿瘤转移

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-024-02274-y
Li, Guanghui; Suo, Daqin; Ma, Yuanzhen; Zeng, Tingting; Zhan, Jiarong; Yuan, Yunfei; Guan, Xin-Yuan; Li, Yan
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma

肝细胞癌中m6A修饰在免疫浸润、代谢和耐药性中的综合分析

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-024-03307-3
Shi, Yunxing; Li, Kai; Yuan, Yichuan; Wang, Chenwei; Yang, Zhiwen; Zuo, Dinglan; Niu, Yi; Qiu, Jiliang; Li, Binkui; Yuan, Yunfei; He, Wei
m6A/m5C/m7G
肿瘤
肿瘤免疫
代谢
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma

PD-L1抑制剂与PD-1抑制剂联合贝伐单抗经血管介入治疗不可切除肝细胞癌的比较

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-024-01415-y
Huang, Zhenkun; Chen, Tiejun; Li, Wenbin; Qiu, Jiliang; Liu, Shaoru; Wu, Zongfeng; Li, Binkui; Yuan, Yunfei; He, Wei
肿瘤
肿瘤免疫
PD-L1
细胞生物学
PD-1
发表日期：2024
文献求助 收藏